Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosalin Mishra

Showing results (21-30 of 23) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 23 results.
Chemmedchem|November 8, 2019
Oxidative Cyclization-Induced Activation of a Phosphoinositide 3-Kinase Inhibitor for Enhanced Selectivity of Cancer ChemotherapeuticsHaizhou Zhu, Rosalin Mishra, Long Yuan, et al.
Expert Opinion on Therapeutic Targets|July 2, 2011
Osteopontin: a potentially important therapeutic target in cancerMansoor Ahmed, Reeti Behera, Goutam Chakraborty, et al.
Expert Opinion on Therapeutic Targets|June 6, 2014
Osteopontin as a therapeutic target for cancerMonalisa Bandopadhyay, Anuradha Bulbule, Ramesh Butti, et al.
Pageof 3

Showing results (21-30 of 23) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 23 results.
Chemmedchem|November 8, 2019
Oxidative Cyclization-Induced Activation of a Phosphoinositide 3-Kinase Inhibitor for Enhanced Selectivity of Cancer ChemotherapeuticsHaizhou Zhu, Rosalin Mishra, Long Yuan, et al.
Expert Opinion on Therapeutic Targets|July 2, 2011
Osteopontin: a potentially important therapeutic target in cancerMansoor Ahmed, Reeti Behera, Goutam Chakraborty, et al.
Expert Opinion on Therapeutic Targets|June 6, 2014
Osteopontin as a therapeutic target for cancerMonalisa Bandopadhyay, Anuradha Bulbule, Ramesh Butti, et al.
Pageof 3